These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11311292)

  • 1. Mycophenolate (CellCept) treatment of myasthenia gravis, chronic inflammatory polyneuropathy and inclusion body myositis.
    Mowzoon N; Sussman A; Bradley WG
    J Neurol Sci; 2001 Apr; 185(2):119-22. PubMed ID: 11311292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases.
    Chaudhry V; Cornblath DR; Griffin JW; O'Brien R; Drachman DB
    Neurology; 2001 Jan; 56(1):94-6. PubMed ID: 11148242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycophenolate mofetil in the therapy of severe myasthenia gravis.
    Schneider C; Gold R; Reiners K; Toyka KV
    Eur Neurol; 2001; 46(2):79-82. PubMed ID: 11528156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of myasthenia gravis with mycophenolate mofetil: a case report.
    Meriggioli MN; Rowin J
    Muscle Nerve; 2000 Aug; 23(8):1287-9. PubMed ID: 10918271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell lymphoproliferative disorder following mycophenolate treatment for myasthenia gravis.
    Dubal DB; Mueller S; Ruben BS; Engstrom JW; Josephson SA
    Muscle Nerve; 2009 Jun; 39(6):849-50. PubMed ID: 19358236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolate mofetil in AChR-antibody-positive myasthenia gravis: outcomes in 102 patients.
    Hehir MK; Burns TM; Alpers J; Conaway MR; Sawa M; Sanders DB
    Muscle Nerve; 2010 May; 41(5):593-8. PubMed ID: 20405499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results of tacrolimus in cyclosporine- and prednisone-dependent myasthenia gravis.
    Ponseti JM; Azem J; Fort JM; López-Cano M; Vilallonga R; Buera M; Cervera C; Armengol M
    Neurology; 2005 May; 64(9):1641-3. PubMed ID: 15883336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolate mofetil for ocular myasthenia.
    Chan JW
    J Neurol; 2008 Apr; 255(4):510-3. PubMed ID: 18299952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can mycophenolate mofetil be tapered safely in myasthenia gravis? A retrospective, multicenter analysis.
    Hobson-Webb LD; Hehir M; Crum B; Visser A; Sanders D; Burns TM
    Muscle Nerve; 2015 Aug; 52(2):211-5. PubMed ID: 25906756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary CNS lymphoma complicating treatment of myasthenia gravis with mycophenolate mofetil.
    Vernino S; Salomao DR; Habermann TM; O'Neill BP
    Neurology; 2005 Aug; 65(4):639-41. PubMed ID: 16116136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolate mofetil for myasthenia gravis: an analysis of efficacy, safety, and tolerability.
    Meriggioli MN; Ciafaloni E; Al-Hayk KA; Rowin J; Tucker-Lipscomb B; Massey JM; Sanders DB
    Neurology; 2003 Nov; 61(10):1438-40. PubMed ID: 14638974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolate mofetil - as an adjunctive immunosuppressive therapy in refractory myasthenia gravis: The Singapore experience.
    Prakash KM; Ratnagopal P; Puvanendran K; Lo YL
    J Clin Neurosci; 2007 Mar; 14(3):278-81. PubMed ID: 16597503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate mofetil for myasthenia gravis: an open-label pilot study.
    Ciafaloni E; Massey JM; Tucker-Lipscomb B; Sanders DB
    Neurology; 2001 Jan; 56(1):97-9. PubMed ID: 11148243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The muddle of mycophenolate mofetil in myasthenia.
    Benatar M; Rowland LP
    Neurology; 2008 Aug; 71(6):390-1. PubMed ID: 18678821
    [No Abstract]   [Full Text] [Related]  

  • 15. Myasthenia gravis with inclusion body myositis: A case report.
    Kakutani T; Yoshizawa M
    Mod Rheumatol Case Rep; 2023 Dec; 8(1):83-85. PubMed ID: 37210209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycophenolate mofetil in myasthenia gravis: the unanswered question.
    Phan C; Sanders DB; Siddiqi ZA
    Expert Opin Pharmacother; 2008 Oct; 9(14):2545-51. PubMed ID: 18778192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myasthenia gravis and chronic inflammatory demyelinating polyneuropathy in the same patient - a case report.
    Quan W; Xia J; Tong Q; Lin J; Zheng X; Yang X; Xie D; Weng Y; Zhang X
    Int J Neurosci; 2018 Jun; 128(6):570-572. PubMed ID: 29073825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate and methotrexate are better tolerated than azathioprine in myasthenia gravis.
    Dodd KC; Ahmed R; Ambrose P; Holt JK; Jacob S; Leite MI; Miller JA; San PP; Spillane J; Viegas S; Sussman J
    Neuromuscul Disord; 2024 May; 38():51-57. PubMed ID: 38626662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of mycophenolate mofetil as a rescue agent in the treatment of severe generalized myasthenia gravis in three dogs.
    Abelson AL; Shelton GD; Whelan MF; Cornejo L; Shaw S; O'Toole TE
    J Vet Emerg Crit Care (San Antonio); 2009 Aug; 19(4):369-74. PubMed ID: 25164637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolate mofetil treatment of myasthenia gravis.
    Cahoon WD; Kockler DR
    Ann Pharmacother; 2006 Feb; 40(2):295-8. PubMed ID: 16403848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.